Gladstone Institute of Virology and Immunology -

GIVI In The News

GIVI Scientists Identify Key Factor That Controls HIV Latency

Scientists Identify Link that May Neutralize HIV

GIVI Investigator Melanie Ott Receives UCSF Chancellor's 2008 Award for Public Service

Gladstone and UCSF Scientists Reactivate Immune Cell Production in HIV-Infected Adults

Gilead Sciences and Gladstone to Collaborate on HIV Targets

Methods of Modulating Mitochondrial NAD-Dependent Deacetylase Patent Issued

Virion-based Fusion Assay Patent Issued

Gladstone Receives CIRM SEED Grants for Research Into HIV Biology, Neurological Disease +Factors Affecting Stem Cell Development

Gladstone Investigators Identify a New Protective Action for the Powerful Anti-HIV Factor APOBEC3G

Institute of Medicine Elects Gladstone Director Warner Greene

Science Commentary Highlights Need for Collaboration at Local Level in International HIV-Prevention Prophylaxis Studies

Warner Greene Named 2004 AAAS Fellow

Joseph M. "Mike" McCune Wins Prestigious NIH Director's Pioneer Award

Gladstone Scientists Discover How HIV Avoids Cell Defenses

The Future of HIV Therapeutics is Brightening, According to Gladstone Institutes Director

Displaying 1 - 15 of 26 item(s) 1 2 Next >>